Abstract:Background The mitochondrial unfolded protein response (UPR mt ) is the first line of defense against mitochondrial dysfunction in several diseases. Baicalein, which is an extract of Scutellaria baicalensis Georgi roots, exerts mitoprotective effects on metabolic disorders and cardiovascular diseases. However, it remains unclear whether baicalein alleviates obesity-induced cardiac damage through the UPR mt . Purpose The present research designed to clarify the role of baicalein in lipotoxicity-induced myocardial apoptosis and investigated the UPR mt -related mechanism. Methods In the in vitro experiment, palmitic acid (PA)-treated AC16 cardiomyocytes were established to mimic obesity-induced myocardial injury. After pretreatment of AC16 cells with baicalein, the levels of cell vitality, apoptosis, mitochondrial membrane potential, mitochondrial oxidative stress, and UPR mt -related proteins were determined. Additionally, AC16 cells were treated with ML385 or siRNA to explore the regulation of the UPR mt by NRF2 signaling. In the in vivo experiment, male db/db mice administered with baicalein for 8 weeks were used to validate the effects of baicalein on cardiac damage induced by obesity, the UPR mt , and the NRF2-related pathway. Results In AC16 cardiomyocytes, PA dose-dependently increased the expression of UPR mt markers (HSP60, LONP1, ATF4, and ATF5). This increase was accompanied by enhanced production of mitochondrial ROS, reduced mitochondrial membrane potential, and elevated the expression levels of cytochrome c , cleaved caspase-3, and Bax/Bcl2, eventually leading to cell apoptosis. Baicalein treatment reversed UPR mt activation and mitochondrial damage and impeded mitochondrial-mediated cell apoptosis. Moreover, NRF2 downregulation by its inhibitor ML385 or siRNA diminished baicalein-mediated NRF2 signaling activation and UPR mt inhibition and triggered mitochondrial dysfunction. Additionally, NRF2 deficiency more intensely activated the UPR mt , resulting in mitochondrial oxidative stress and apoptosis of PA-induced cardiomyocytes, thus indicating that NRF2 plays a vital role in mitochondrial homeostasis regulation. In the in vivo study in db/db mice, baicalein inhibited the UPR mt , enhanced the antioxidant capacity, and attenuated cardiac dysfunction through a NRF2-activated pathway. Conclusion To our best knowledge, these results provide the first insight that baicalein inhibits the UPR mt to induce a protective effect against lipotoxicity-induced mitochondrial damage and cardiomyocyte apoptosis via activating NRF2 signaling and suggest a new role of NRF2 in UPR mt regulation.

Baicalein, an active component of Scutellaria baicalensis Georgi, improves cardiac contractile function in endotoxaemic rats via induction of heme oxygenase-1 and suppression of inflammatory responses

Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy

Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro

Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2.

Baicalein Attenuates Lung Injury Induced by Myocardial Ischemia and Reperfusion

Baicalein Ameliorates Myocardial Ischemia Through Reduction of Oxidative Stress, Inflammation and Apoptosis via TLR4/MyD88/MAPKS/NF-κB Pathway and Regulation of Ca2+ Homeostasis by L-type Ca2+ Channels

Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats

Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes

Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice.

Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF‑κB signaling pathway

Pulmonary , gastrointestinal and urogenital pharmacology Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of in fl ammation and apoptosis in mice

Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.

Baicalein Exerts Therapeutic Effects against Endotoxin-Induced Depression-like Behavior in Mice by Decreasing Inflammatory Cytokines and Increasing Brain-Derived Neurotrophic Factor Levels

Baicalein Attenuates Severe Polymicrobial Sepsis Via Alleviating Immune Dysfunction of T Lymphocytes and Inflammation

Effects of Baicalein on Rat Myocardial Ischemia and Neonatal Cardiomyocyte Injury

Baicalein attenuates the neuroinflammation in LPS-activated BV-2 microglial cells through suppression of pro-inflammatory cytokines, COX2/NF-κB expressions and regulation of metabolic abnormality

Cytoprotection of Baicalein Against Oxidative Stress-induced Cardiomyocytes Injury Through the Nrf2/Keap1 Pathway

Baicalein Reduces the Occurrence of Cirrhotic Endotoxemia by Reducing Intestinal Mucosal Apoptosis

Baicalein Pretreatment Protects Against Liver Ischemia/reperfusion Injury Via Inhibition of NF-κB Pathway in Mice

Baicalein ameliorated obesity-induced cardiac dysfunction by regulating the mitochondrial unfolded protein response through NRF2 signaling

Baicalin Protects the Cardiomyocytes from ER Stress-Induced Apoptosis: Inhibition of CHOP Through Induction of Endothelial Nitric Oxide Synthase.